Literature DB >> 11683083

[Evaluation of diagnosis and follow-up in screened children with cystic fibrosis in Normandy].

J Brouard1, I Lecoq, J F Viel, M Guillot, M Laurans, D Laroche, G Travert, J F Duhamel.   

Abstract

The neonatal screening programme in Normandy (France) allowed the formation of a homogenous cystic fibrosis (CF) cohort of 150 children diagnosed between 1980 and 1997. At the time of this retrospective study, 11 were deceased, out of which nine had meconium ileus (eight deaths after surgery, one at 5 years of age). Sixty children born between 1980 and 1993 in the Basse-Normandie region were followed up during a mean 80 months following similar protocols. The mean age at diagnosis was 41 days (SD = 27 d) for infants without meconium ileus. The occurrence of Pseudomonas aeruginosa (P. aeruginosa) infection and chronic colonization was studied using a monovariate followed by a multivariate analysis including the following variables: sex; meconium ileus; anthropometric data at birth and at diagnosis; pancreatic insufficiency; radiological data (Brasfield score); microbiology data at diagnosis; and genetic data. P. aeruginosa infection appeared earlier in children with pancreatic insufficiency (OR = 2.2; p < 0.05) or with radiological abnormalities (Brasfield score < 21) at diagnosis (OR = 3.9; p < 0.05). Meconium ileus (OR = 5.3; p < 0.01), pancreatic insufficiency (OR = 3.8; p < 0.01) and Brasfield score < 21 at diagnosis (OR = 5.6; p < 0.001) were prognosis factors for early chronic P. aeruginosa colonization. In CF children without meconium ileus, the major risk factor found through multivariate analysis for earlier infection and for earlier chronic colonization by P. aeruginosa was a diagnosis delay > 40 days (respectively OR = 4.6; p < 0.001 and OR = 10.4; p < 0.005). These results must be compared with the lower Brasfield score at diagnosis in infants diagnosed after 40 days of life (p < 0.01).

Entities:  

Mesh:

Year:  2001        PMID: 11683083     DOI: 10.1016/s0929-693x(01)80015-4

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  Variants in Solute Carrier SLC26A9 Modify Prenatal Exocrine Pancreatic Damage in Cystic Fibrosis.

Authors:  Melissa R Miller; David Soave; Weili Li; Jiafen Gong; Rhonda G Pace; Pierre-Yves Boëlle; Garry R Cutting; Mitchell L Drumm; Michael R Knowles; Lei Sun; Johanna M Rommens; Frank Accurso; Peter R Durie; Harriet Corvol; Hara Levy; Marci K Sontag; Lisa J Strug
Journal:  J Pediatr       Date:  2015-03-11       Impact factor: 4.406

2.  Cystic fibrosis in Tunisian children: a review of 32 children.

Authors:  Khedija Boussetta; Fatma Khalsi; Yasmine Bahri; Imen Belhadj; Faten Tinsa; Taieb Ben Messaoud; Samia Hamouda
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.